Table 3 Summary of the average of domain scores of DXA Guidelines according to AGREE II
Guideline title | Domain 1 | Domain 2 | Domain 3 | Domain 4 | Domain 5 | Domain 6 | Total score mean (SD) | Overall quality |
|---|---|---|---|---|---|---|---|---|
Recommendations for BMD Reporting in Canada [8] | 84.7%* (good) | 73.6%* (acceptable) | 57.3% (low) | 77.8%* (acceptable) | 66.7%* (acceptable) | 75.0%* (acceptable) | 72.5% (9.5%) | High |
ISCD 2007 Adult and Pediatric Official Positions [7] | 91.7%* (good) | 76.4%* (acceptable) | 78.6%* (acceptable) | 90.3%* (good) | 78.1%* (acceptable) | 41.7% (low) | 76.1% (18,1%) | High |
ACR Appropriateness Criteria: Osteoporosis and BMD [10] | 88.9%* (good) | 68.1%* (acceptable) | 60.9%* (acceptable) | 87.5%* (good) | 76.0%* (acceptable) | 54.2% (low) | 72.6% (14.1%) | High |
ACR-SPR-SSR Practice Parameter for the Performance of DXA [9] | 81.9%* (good) | 68.1%* (acceptable) | 58.9% (low) | 66.7%* (acceptable) | 61.5%* (acceptable) | 47.9% (low) | 64.1% (11.3%) | Average |
Total domain score; mean (SD) | 86,8% (3,7%) (good) | 71,5% (3.6%) (acceptable) | 63.9% (8.6%) (acceptable) | 80.6% (9.3%) (good) | 70.6% (6.8%) (acceptable) | 54.7% (12.5%) (low) |